
| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 60 | 21.3x | 17.3x | Around median | |
Growth | 72 | 15.9% | 7.1% | Top tier | |
Quality | 64 | 9.0% | 4.5% | Around median | |
Safety | 93 | 0.1x | 2.6x | Top tier | |
Capital Return | 27 | 0.00% | 0.06% | Bottom tier | |
Momentum | 86 | -0.4% | -1.6% | Top tier | |
Sentiment | 63 | 9 | 3 | Around median |
The floor: what the company is worth if growth stopped today
47% of today's price is what a buyer pays for growth that has not happened yet.
10-year US Treasury yield 4.96% as of 2026-10-22. Estimates computed from company data and analyst targets, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Addus HomeCare Corporation provides home-based care services through three interconnected lines: personal care, hospice care, and home health care. The company generates most of its revenue from personal care, while using clinical services to complete the continuum of care and strengthen its relationships with states and managed care organizations; in Q2 FY2026, personal care revenue was $296 million, or 78.4% of the total, compared with $64.2 million for hospice care, or 17%, and $17.2 million for home health care, or 4.6%.
In Q2 FY2026, total revenue increased 8% year over year to $377.4 million, and gross profit reached $121.6 million with a gross margin of 32.2%, compared with a margin of 32.6% in Q2 FY2025. Net income was $27.6 million and GAAP earnings per share were $1.49, while adjusted earnings per share increased 16.1% to $1.73, and adjusted earnings before interest, taxes, depreciation, and amortization grew 11.9% to $49.2 million with a margin of 13%.
The results showed uneven growth across the businesses; personal care same-store revenue increased 6.8% as hours rose 2.2%, and hospice care same-store revenue increased 11.1% as average daily census grew 6.5% to 3,964 patients. By contrast, home health care same-store revenue declined 2.8%, although this was an improvement from a 6.6% decline in Q1 FY2026, alongside sequential improvements in revenue, operating income, and admissions.
The analyst consensus rates ADUS stock a “Buy,” with an average price target of $118.33 and a wide range between $96 and $134, reflecting meaningful differences in assessments of the impact of operational growth and reimbursement and regulatory risks. The average target is approximately 4.9% below the 52-week range high of $124.44, while the highest target exceeds that high and the lowest target remains above the range low of $87.95; therefore, the valuation combines positive growth expectations with clear caution among some analysts.
Figures in the text are as of 2026-09-15; the live price is shown at the top of the page.
Personal care was the largest driver, with revenue of $296 million representing 78.4% of total Q2 FY2026 revenue. Same-store revenue in this business increased 6.8%, and same-store daily hours increased 2.2%. The segment also benefited from a 9.9% reimbursement increase in Texas and a 3.9% increase in Illinois. The authorized hours fulfillment rate was between 84% and 85%, leaving room for further growth if it approaches the targeted upper-80% range.
In Q2 FY2026, revenue increased 8% to $377.4 million, while adjusted earnings before interest, taxes, depreciation, and amortization increased 11.9% to $49.2 million. Adjusted earnings per share rose 16.1% to $1.73, and net income according to EDGAR was approximately $27.6 million. The adjusted earnings before interest, taxes, depreciation, and amortization margin improved from 12.6% to 13%, but gross margin declined year over year from 32.6% to 32.2%. Management expects a full-year margin between 12% and 13% for FY2026.
Automated analysis for informational purposes only — not investment advice.
The app helps Addus match caregivers with authorized hours, which is important because management considers caregiver availability the primary constraint on organic growth. Usage exceeded 90% in Illinois, while the rollout in Texas raised the hours fulfillment rate to the mid-80% range, approaching the upper end during Q2 FY2026. Progress in New Mexico was slower because the company operates through the state's electronic visit verification app. Management also said caregiver turnover declined slightly alongside use of the app and a shorter period between hiring and the first client assignment.
Hospice care generated revenue of $64.2 million, or 17% of total Q2 FY2026 revenue. Same-store revenue increased 11.1%, and average daily census rose 6.5% to 3,964 patients, then exceeded 4,000 in July 2026. Average length of stay increased to 24 days, compared with 22 days in Q2 FY2025. By contrast, the segment recorded an expense of slightly more than $3 million due to the Medicare cap, with the impact concentrated primarily in Ohio.
Cash was $99.6 million as of June 30, 2026, compared with bank debt of $64.3 million after repaying $30 million during the quarter. Total credit facility capacity was $650 million, of which $577.8 million was available. The company generated operating cash flow of $40 million during Q2 FY2026. However, management expects cash flow to moderate in the second half, because approximately $20 million of the first-half improvement was related to working capital benefits.
On May 1, 2026, Addus closed the acquisition of HomeCourt Home Care's personal care operations in Fort Wayne, Indiana, and the transaction contributed two months to Q2 FY2026 results. Management said HomeCourt's business volume slightly exceeded its expectations and that its proximity to Illinois, Ohio, and Michigan facilitated its integration under the regional leadership teams. The company also signed a definitive agreement to acquire operating assets from a similarly sized personal care provider in the Indianapolis area, with closing subject to customary conditions and regulatory review. Addus plans to combine the second operation with the HomeCourt platform to build geographic density and greater scale in Indiana.